Clinical trial
Sep 2026
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial
Xing-Hao Ai, Zheng-Bo Song, Lin Wu et al.
· Nature Medicine · 1 citation